| 赵婧雨,韩沛恩,付亚群,杨莉,任涛,詹思延,李立明.新型冠状病毒疫苗接种策略经济学评价研究进展[J].Chinese journal of Epidemiology,2022,43(4):460-465 |
| 新型冠状病毒疫苗接种策略经济学评价研究进展 |
| Progress in research of economic evaluation of COVID-19 vaccination strategies |
| Received:December 10, 2021 |
| DOI：10.3760/cma.j.cn112338-20211210-00967 |
| KeyWord: 新型冠状病毒肺炎|疫苗接种|经济学评价 |
| English Key Word: COVID-19|Vaccination|Economic evaluation |
| FundProject:国家自然科学基金（72174010）；北京自然科学基金专项（M22033）；首都卫生发展科研专项（2021-1G-4091） |
| Author Name | Affiliation | E-mail | | Zhao Jingyu | School of Public Health, Peking University, Beijing 100191, China | | | Han Peien | School of Public Health, Peking University, Beijing 100191, China | | | Fu Yaqun | School of Public Health, Peking University, Beijing 100191, China | | | Yang Li | School of Public Health, Peking University, Beijing 100191, China | lyang@bjmu.edu.cn | | Ren Tao | School of Public Health, Peking University, Beijing 100191, China | | | Zhan Siyan | School of Public Health, Peking University, Beijing 100191, China | | | Li Liming | School of Public Health, Peking University, Beijing 100191, China
Peking University Center for Public Health and Epidemic Preparedness & Response, Beijing 100191, China | |
|
| Hits: 3420 |
| Download times: 897 |
| Abstract: |
| 目的 了解国内外新型冠状病毒疫苗（新冠疫苗）接种策略相关的经济学评价研究进展，为开展基于中国真实世界证据疫苗接种策略经济学评价提供参考。方法 对中英文数据库2020年1月至2021年12月的文献进行检索，纳入新冠疫苗接种策略经济学评价研究，并对相关文献进行叙述性整合。结果 共纳入16篇英文文献（含3篇综述），发现无论品种，接种新冠疫苗都具有成本效果或节省成本，但不同人群和剂次接种策略的成本效果由于受疫苗有效率、价格、自然免疫持续时间、接种策略持续时长、供应情况、接种速度的影响而不同。结论 国内缺少长期疫情流行趋势下基于中国真实世界证据的新冠疫苗接种策略经济学评价证据，对于疫苗加强针接种的合理策略仍需进一步研究。 |
| English Abstract: |
| Objective To understand the research progresses of economic evaluation of COVID-19 vaccination strategies both at home and abroad, and provide reference for the economic evaluation of COVID-19 vaccination strategies using real word data in China. Methods Literature retrieval was conducted for related papers published from January, 2020 to December, 2021 in Chinese and English databases, including the economic evaluation of COVID-19 vaccination, and the results of the related literatures were narratively integrated. Results A total of 16 English literatures (including 3 reviews) were included, and it was found that the COVID-19 vaccination was cost-effective or cost-saving regardless of the vaccine types, while the cost-effectiveness in different population and under different vaccination dose strategies varied due to vaccine efficacy, vaccine price, duration of natural immunity, duration of vaccination campaign, vaccine supply, and vaccination pace. Conclusions China lacks suitable evidences of economic evaluation of COVID-19 vaccination strategies based on real-world data in the context of long-term epidemic. Therefore, further researches of suitable strategies of booster COVID-19 vaccination are needed. |
|
View Fulltext
Html FullText
View/Add Comment Download reader |
| Close |
|
|
|